Wave Life Sciences Ltd.

NasdaqGM:WVE 株式レポート

時価総額:US$638.0m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Wave Life Sciences 将来の成長

Future 基準チェック /26

Wave Life Sciencesは、12.4%と30.2%でそれぞれ年率12.4%で利益と収益が成長すると予測される一方、EPSはgrowで20.3%年率。

主要情報

10.0%

収益成長率

18.4%

EPS成長率

Pharmaceuticals 収益成長27.6%
収益成長率29.4%
将来の株主資本利益率n/a
アナリストカバレッジ

Good

最終更新日25 Jun 2024

今後の成長に関する最新情報

Recent updates

Pinning Down Wave Life Sciences Ltd.'s (NASDAQ:WVE) P/S Is Difficult Right Now

Jun 25
Pinning Down Wave Life Sciences Ltd.'s (NASDAQ:WVE) P/S Is Difficult Right Now

We Think Wave Life Sciences (NASDAQ:WVE) Can Easily Afford To Drive Business Growth

Apr 09
We Think Wave Life Sciences (NASDAQ:WVE) Can Easily Afford To Drive Business Growth

Wave Life Sciences' Weighty Ambition: Carving Out Obesity Niche

Mar 09

Wave Life Sciences Ltd.'s (NASDAQ:WVE) 30% Price Boost Is Out Of Tune With Revenues

Mar 03
Wave Life Sciences Ltd.'s (NASDAQ:WVE) 30% Price Boost Is Out Of Tune With Revenues

We're Interested To See How Wave Life Sciences (NASDAQ:WVE) Uses Its Cash Hoard To Grow

Sep 13
We're Interested To See How Wave Life Sciences (NASDAQ:WVE) Uses Its Cash Hoard To Grow

Wave Life Sciences Ltd. (NASDAQ:WVE) Analysts Just Cut Their EPS Forecasts Substantially

May 08
Wave Life Sciences Ltd. (NASDAQ:WVE) Analysts Just Cut Their EPS Forecasts Substantially

Here's Why Wave Life Sciences (NASDAQ:WVE) Must Use Its Cash Wisely

Mar 30
Here's Why Wave Life Sciences (NASDAQ:WVE) Must Use Its Cash Wisely

Are Investors Undervaluing Wave Life Sciences Ltd. (NASDAQ:WVE) By 47%?

Jan 20
Are Investors Undervaluing Wave Life Sciences Ltd. (NASDAQ:WVE) By 47%?

Some Analysts Just Cut Their Wave Life Sciences Ltd. (NASDAQ:WVE) Estimates

Nov 11
Some Analysts Just Cut Their Wave Life Sciences Ltd. (NASDAQ:WVE) Estimates

Is Wave Life Sciences (NASDAQ:WVE) In A Good Position To Deliver On Growth Plans?

Aug 12
Is Wave Life Sciences (NASDAQ:WVE) In A Good Position To Deliver On Growth Plans?

Wave Life Sciences Q2 2022 Earnings Preview

Aug 10

Will Wave Life Sciences (NASDAQ:WVE) Spend Its Cash Wisely?

Apr 21
Will Wave Life Sciences (NASDAQ:WVE) Spend Its Cash Wisely?

Is Wave Life Sciences (NASDAQ:WVE) In A Good Position To Invest In Growth?

Jan 11
Is Wave Life Sciences (NASDAQ:WVE) In A Good Position To Invest In Growth?

We Think Wave Life Sciences (NASDAQ:WVE) Needs To Drive Business Growth Carefully

Sep 24
We Think Wave Life Sciences (NASDAQ:WVE) Needs To Drive Business Growth Carefully

What Does The Future Hold For Wave Life Sciences Ltd. (NASDAQ:WVE)? These Analysts Have Been Cutting Their Estimates

Aug 07
What Does The Future Hold For Wave Life Sciences Ltd. (NASDAQ:WVE)? These Analysts Have Been Cutting Their Estimates

Wave Life Sciences posts proof-of-concept data from genetic disorder study

Jun 02

Wave Life Sciences Ltd. (NASDAQ:WVE) Analysts Just Slashed This Year's Estimates

May 15
Wave Life Sciences Ltd. (NASDAQ:WVE) Analysts Just Slashed This Year's Estimates

Things Look Grim For Wave Life Sciences Ltd. (NASDAQ:WVE) After Today's Downgrade

Apr 02
Things Look Grim For Wave Life Sciences Ltd. (NASDAQ:WVE) After Today's Downgrade

Wave Life Sciences (NASDAQ:WVE) Share Prices Have Dropped 80% In The Last Three Years

Feb 19
Wave Life Sciences (NASDAQ:WVE) Share Prices Have Dropped 80% In The Last Three Years

業績と収益の成長予測

NasdaqGM:WVE - アナリストの将来予測と過去の財務データ ( )USD Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
12/31/202684-119-189-1375
12/31/202551-139-135-1267
12/31/202475-90-131-1164
3/31/2024113-62-139-138N/A
12/31/2023113-58-21-19N/A
9/30/202385-85-21-20N/A
6/30/202337-131-12-11N/A
3/31/202315-151-4-2N/A
12/31/20224-162-129-128N/A
9/30/20224-153-103-101N/A
6/30/202240-120-105-104N/A
3/31/202243-118-85-84N/A
12/31/202141-122-90-89N/A
9/30/202149-116-114-113N/A
6/30/202116-143-106-105N/A
3/31/202116-145-135-134N/A
12/31/202020-150-117-116N/A
9/30/202013-178-148-146N/A
6/30/202013-196-172-169N/A
3/31/202017-197-168-164N/A
12/31/201916-194-192-188N/A
9/30/201917-175-166-160N/A
6/30/201919-162-154-145N/A
3/31/201916-156-50-41N/A
12/31/201814-147-33-23N/A
9/30/201812-140-23-13N/A
6/30/20189-127-20-7N/A
3/31/20185-116-115-99N/A
12/31/20174-102N/A-84N/A
9/30/20173-90N/A-74N/A
6/30/20173-82N/A-63N/A
3/31/20172-69N/A-42N/A
12/31/20161-56N/A-32N/A
9/30/20161-44N/A-25N/A
6/30/20160-31N/A-16N/A
3/31/20160-24N/A-18N/A
12/31/20150-19N/A-13N/A
9/30/20150-14N/A-7N/A
6/30/20150-10N/A-5N/A
3/31/20150-8N/A-5N/A
12/31/2014N/A-5N/A-4N/A

アナリストによる今後の成長予測

収入対貯蓄率: WVE今後 3 年間、利益が出ない状態が続くと予測されています。

収益対市場: WVE今後 3 年間、利益が出ない状態が続くと予測されています。

高成長収益: WVE今後 3 年間、利益が出ない状態が続くと予測されています。

収益対市場: WVEの収益 ( 30.2% ) US市場 ( 8.7% ) よりも速いペースで成長すると予測されています。

高い収益成長: WVEの収益 ( 29.8% ) 20%よりも速いペースで成長すると予測されています。


一株当たり利益成長率予想


将来の株主資本利益率

将来のROE: WVEの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です


成長企業の発掘